ScieGen Pharmaceuticals Competitors and Similar CompaniesClear all

ScieGen Pharmaceuticals's competitors and similar companies include Zydus Lifesciences, Aoxing Pharmaceutical, Grupo Menarini and Medochemie.

	ScieGen Pharmaceuticals ScieGen Pharmaceuticals is a generic pharmaceutical company.	Zydus Lifesciences Zydus Lifesciences (formerly known as Cadila Healthcare) is a company that provides healthcare solutions.	Aoxing Pharmaceutical Aoxing Pharmaceutical is a specialty pharmaceutical company.	Grupo Menarini Grupo Menarini is a pharmaceutical company.	Medochemie Medochemie is a pharmaceutical company.
Founding Date	Founding Date 2010	Founding Date 1952	Founding Date 2002	Founding Date 1961	Founding Date 1976
Type	Type Private	Type Public	Type Public	Type Private	Type Private
Tags	Tags Healthcare distribution drug development pharma	Tags Healthcare distribution drug development pharma	Tags Healthcare distribution drug development pharma	Tags Healthcare distribution drug development pharma	Tags Healthcare distribution drug development pharma
Locations	Locations Hauppauge, US HQ Hyderabad, IN Hauppauge, US	Locations Ahmedabad, IN HQ Rio De Janeiro, BR Nanterre, FR Ahmedabad, IN Ambernath, IN Ankleshwar, IN Bengaluru, IN see more	Locations Shijiazhuang Shi, CN HQ Shijiazhuang Shi, CN Foster City, US	Locations Badalona, ES HQ	Locations Λεμεσός, CY HQ Ben Aknoun, DZ Amman, JO Rīga, LV Chișinău, MD Moscow, RU
Employees	Employees 1722% increase	Employees 27,9176% increase	Employees 346	Employees 5541% increase	Employees 825
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ₹267.2b (FY, 2026)	Revenue (est.) $32.3m (FY, 2016)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods ₹72.9b (FY, 2026)	Cost of goods $7.8m (FY, 2016)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit ₹203.7b (FY, 2026)	Gross profit $24.6m (FY, 2016)	Gross profit N/A	Gross profit N/A
Net income	Net income N/A	Net income ₹50.3b (FY, 2026)	Net income $2.1m (FY, 2016)	Net income N/A	Net income N/A